Figure 3.
Freedom from primary endpoint at 376 ± 18.1 days of follow-up (MACE: cardiovascular death, acute myocardial infarction, target lesion revascularization) according to residual scores (>5 and ⩽5), SYNTAX, and ERACI score. (A) Residual SYNTAX score. (B) Residual ERACI score. MACE indicates major adverse cardiac events.